Physiology: TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-κB signaling pathway

Science Signaling

Volumn 5, Issue 246, 2012, Pages

  Enwere, Emeka K ^a,b   Holbrook, Janelle ^b   Lejmi Mrad, Rim ^a,b   Vineham, Jennifer ^a,b   Timusk, Kristen ^a,b   Sivaraj, Baktharaman ^c   Isaac, Methvin ^c   Uehling, David ^c   Al awar, Rima ^c   LaCasse, Eric ^b   Korneluk, Robert G ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR INHIBITOR OF APOPTOSIS 1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN P100; PROTEIN P52; TNF LIKE WEAK INDUCER OF APOPTOSIS PROTEIN; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG; BROXURIDINE; INHIBITOR OF APOPTOSIS PROTEIN; SMALL INTERFERING RNA; TNFSF12 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; GENE SILENCING; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; BIOLOGICAL MODEL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METABOLISM; MUSCLE; PHYSIOLOGY; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; BROMODEOXYURIDINE; CELL LINE; GENE EXPRESSION REGULATION; GENOTYPE; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; MUSCLES; MYOBLASTS; NF-KAPPA B; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS;

EID: 84867805394     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003086     Document Type: Article

References (73)

1. S. M. Abmayr, G. K. Pavlath, Myoblast fusion: Lessons from flies and mice. Development 139, 641-656 (2012).
2. P. Liston, N. Roy, K. Tamai, C. Lefebvre, S. Baird, G. Cherton-Horvat, R. Farahani, M. McLean, J. E. Ikeda, A. MacKenzie, R. G. Korneluk, Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379, 349-353 (1996).
3. T. Samuel, K. Welsh, T. Lober, S. H. Togo, J. M. Zapata, J. C. Reed, Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J. Biol. Chem. 281, 1080-1090 (2006).
4. C. S. Duckett, V. E. Nava, R. W. Gedrich, R. J. Clem, J. L. Van Dongen, M. C. Gilfillan, H. Shiels, J. M. Hardwick, C. B. Thompson, A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 15, 2685-2694 (1996).
5. Y. Yang, S. Fang, J. P. Jensen, A. M. Weissman, J. D. Ashwell, Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874-877 (2000).
6. C. Du, M. Fang, Y. Li, L. Li, X. Wang, Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42 (2000).
7. Z. Liu, C. Sun, E. T. Olejniczak, R. P. Meadows, S. F. Betz, T. Oost, J. Herrmann, J. C. Wu, S. W. Fesik, Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 408, 1004-1008 (2000).
8. E. C. LaCasse, D. J. Mahoney, H. H. Cheung, S. Plenchette, S. Baird, R. G. Korneluk, IAP-targeted therapies for cancer. Oncogene 27, 6252-6275 (2008).
9. R. Feltham, B. Bettjeman, R. Budhidarmo, P. D. Mace, S. Shirley, S. M. Condon, S. K. Chunduru, M. A. McKinlay, D. L. Vaux, J. Silke, C. L. Day, Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization. J. Biol. Chem. 286, 17015-17028 (2011).
10. E. C. Dueber, A. J. Schoeffler, A. Lingel, J. M. Elliott, A. V. Fedorova, A. M. Giannetti, K. Zobel, B. Maurer, E. Varfolomeev, P. Wu, H. J. Wallweber, S. G. Hymowitz, K. Deshayes, D. Vucic, W. J. Fairbrother, Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science 334, 376-380 (2011).
11. D. J. Mahoney, H. H. Cheung, R. L. Mrad, S. Plenchette, C. Simard, E. Enwere, V. Arora, T. W. Mak, E. C. Lacasse, J. Waring, R. G. Korneluk, Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc. Natl. Acad. Sci. U.S.A. 105, 11778- 11783 (2008).
12. E. Varfolomeev, J. W. Blankenship, S. M. Wayson, A. V. Fedorova, N. Kayagaki, P. Garg, K. Zobel, J. N. Dynek, L. O. Elliott, H. J. Wallweber, J. A. Flygare, W. J. Fairbrother, K. Deshayes, V. M. Dixit, D. Vucic, IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669 -681 (2007).
13. B. J. Zarnegar, Y. Wang, D. J. Mahoney, P. W. Dempsey, H. H. Cheung, J. He, T. Shiba, X. Yang, W. C. Yeh, T. W. Mak, R. G. Korneluk, G. Cheng, Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378 (2008).
14. J. E. Vince, W. W. Wong, N. Khan, R. Feltham, D. Chau, A. U. Ahmed, C. A. Benetatos, S. K. Chunduru, S. M. Condon, M. McKinlay, R. Brink, M. Leverkus, V. Tergaonkar, P. Schneider, B. A. Callus, F. Koentgen, D. L. Vaux, J. Silke, IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell 131, 682-693 (2007).
15. M. J. Bertrand, S. Milutinovic, K. M. Dickson, W. C. Ho, A. Boudreault, J. Durkin, J. W. Gillard, J. B. Jaquith, S. J. Morris, P. A. Barker, cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689- 700 (2008).
16. E. Varfolomeev, T. Goncharov, H. Maecker, K. Zobel, L. G. Kömüves, K. Deshayes, D. Vucic, Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors. Sci. Signal. 5, ra22 (2012).
17. U. Senftleben, Y. Cao, G. Xiao, F. R. Greten, G. Krahn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S. C. Sun, M. Karin, Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495-1499 (2001).
18. N. J. Solan, H. Miyoshi, E. M. Carmona, G. D. Bren, C. V. Paya, RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem. 277, 1405-1418 (2002).
19. N. Bakkar, J. Wang, K. J. Ladner, H. Wang, J. M. Dahlman, M. Carathers, S. Acharyya, M. A. Rudnicki, A. D. Hollenbach, D. C. Guttridge, IKK/NF-κB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 180, 787-802 (2008).
20. D. C. Guttridge, C. Albanese, J. Y. Reuther, R. G. Pestell, A. S. Baldwin Jr., NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19, 5785-5799 (1999).
21. D. Coletti, E. Yang, G. Marazzi, D. Sassoon, TNFα inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J. 21, 631-642 (2002).
22. S. R. Broussard, R. H. McCusker, J. E. Novakofski, K. Strle, W. H. Shen, R. W. Johnson, R. Dantzer, K. W. Kelley, IL-1β impairs insulin-like growth factor I-induced differentiation and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. J. Immunol. 172, 7713-7720 (2004).
23. N. Mitin, A. J. Kudla, S. F. Konieczny, E. J. Taparowsky, Differential effects of Ras signaling through NFκB on skeletal myogenesis. Oncogene 20, 1276-1286 (2001).
24. H. Li, A. Mittal, P. K. Paul, M. Kumar, D. S. Srivastava, S. C. Tyagi, A. Kumar, Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-κB-inducing kinase and p38 mitogen-activated protein kinase: A potential role of MMP-9 in myopathy. J. Biol. Chem. 284, 4439-4450 (2009).
25. C. Dogra, H. Changotra, S. Mohan, A. Kumar, Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-κB and degradation of MyoD protein. J. Biol. Chem. 281, 10327-10336 (2006).
26. D. B. Conze, L. Albert, D. A. Ferrick, D. V. Goeddel, W. C. Yeh, T. Mak, J. D. Ashwell, Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol. Cell. Biol. 25, 3348-3356 (2005).
27. G. K. Pavlath, V. Horsley, Cell fusion in skeletal muscle - Central role of NFATC2 in regulating muscle cell size. Cell Cycle 2, 420-423 (2003).
28. J. Canicio, P. Ruiz-Lozano, M. Carrasco, M. Palacin, K. Chien, A. Zorzano, P. Kaliman, Nuclear factor κB-inducing kinase and IκB kinase-α signal skeletal muscle cell differentiation. J. Biol. Chem. 276, 20228-20233 (2001).
29. L. Kashima, M. Toyota, H. Mita, H. Suzuki, M. Idogawa, K. Ogi, Y. Sasaki, T. Tokino, CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-κB. Oncogene 28, 2643- 2653 (2009).
30. D. E. Christofferson, Y. Li, J. Hitomi, W. Zhou, C. Upperman, H. Zhu, S. A. Gerber, S. Gygi, J. Yuan, A novel role for RIP1 kinase in mediating TNFα production. Cell Death Dis. 3, e320 (2012).
31. J. E. Vince, D. Chau, B. Callus, W. W. Wong, C. J. Hawkins, P. Schneider, M. McKinlay, C. A. Benetatos, S. M. Condon, S. K. Chunduru, G. Yeoh, R. Brink, D. L. Vaux, J. Silke, TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFα. J. Cell Biol. 182, 171-184 (2008).
32. S. L. Petersen, L. Wang, A. Yalcin-Chin, L. Li, M. Peyton, J. Minna, P. Harran, X. Wang, Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12, 445 -456 (2007).
33. G. Bonizzi, M. Bebien, D. C. Otero, K. E. Johnson-Vroom, Y. Cao, D. Vu, A. G. Jegga, B. J. Aronow, G. Ghosh, R. C. Rickert, M. Karin, Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J. 23, 4202-4210 (2004).
34. C. Dogra, H. Changotra, N. Wedhas, X. Qin, J. E. Wergedal, A. Kumar, TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J. 21, 1857-1869 (2007).
35. A. Mittal, S. Bhatnagar, A. Kumar, E. Lach-Trifilieff, S. Wauters, H. Li, D. Y. Makonchuk, D. J. Glass, A. Kumar, The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J. Cell Biol. 188, 833-849 (2010).
36. C. Dogra, S. L. Hall, N. Wedhas, T. A. Linkhart, A. Kumar, Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis. J. Biol. Chem. 282, 15000-15010 (2007).
37. M. Girgenrath, S. Weng, C. A. Kostek, B. Browning, M. Wang, S. A. Brown, J. A. Winkles, J. S. Michaelson, N. Allaire, P. Schneider, M. L. Scott, Y. M. Hsu, H. Yagita, R. A. Flavell, J. B. Miller, L. C. Burkly, T. S. Zheng, TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J. 25, 5826-5839 (2006).
38. R. Feltham, M. Moulin, J. E. Vince, P. D. Mace, W. W. Wong, H. Anderton, C. L. Day, D. L. Vaux, J. Silke, Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding. J. Biol. Chem. 285, 17525-17536 (2010).
39. T. C. Polek, M. Talpaz, B. G. Darnay, T. Spivak-Kroizman, TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor. J. Biol. Chem. 278, 32317-32323 (2003).
40. E. Gredinger, A. N. Gerber, Y. Tamir, S. J. Tapscott, E. Bengal, Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J. Biol. Chem. 273, 10436-10444 (1998).
41. C. Jo, B. G. Jang, S. A. Jo, MEK1 plays contrary stage-specific roles in skeletal myogenic differentiation. Cell. Signal. 21, 1910-1917 (2009).
42. J. Li, S. E. Johnson, ERK2 is required for efficient terminal differentiation of skeletal myoblasts. Biochem. Biophys. Res. Commun. 345, 1425-1433 (2006).
43. H. Shi, E. Boadu, F. Mercan, A. M. Le, R. J. Flach, L. Zhang, K. J. Tyner, B. B. Olwin, A. M. Bennett, MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy. FASEB J. 24, 2985-2997 (2010).
44. 2+ signals to human myoblast differentiation and fusion. Development 133, 3107-3114 (2006).
45. K. M. Jansen, G. K. Pavlath, Molecular control of mammalian myoblast fusion. Methods Mol. Biol. 475, 115-133 (2008).
46. B. S. Cowling, M. J. McGrath, M. A. Nguyen, D. L. Cottle, A. J. Kee, S. Brown, J. Schessl, Y. Zou, J. Joya, C. G. Bönnemann, E. C. Hardeman, C. A. Mitchell, Identification of FHL1 as a regulator of skeletal muscle mass: Implications for human myopathy. J. Cell Biol. 183, 1033-1048 (2008).
47. N. Bakkar, K. Ladner, B. D. Canan, S. Liyanarachchi, N. C. Bal, M. Pant, M. Periasamy, Q. Li, P. M. Janssen, D. C. Guttridge, IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. J. Cell Biol. 196, 497-511 (2012).
48. S. Acharyya, S. M. Sharma, A. S. Cheng, K. J. Ladner, W. He, W. Kline, H. Wang, M. C. Ostrowski, T. H. Huang, D. C. Guttridge, TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: Implications in Duchenne muscular dystrophy. PLoS One 5, e12479 (2010).
49. C. Tubaro, C. Arcuri, I. Giambanco, R. Donato, S100B in myoblasts regulates the transition from activation to quiescence and from quiescence to activation and reduces apoptosis. Biochim. Biophys. Acta 1813, 1092- 1104 (2011).
50. H. Wang, E. Hertlein, N. Bakkar, H. Sun, S. Acharyya, J. Wang, M. Carathers, R. Davuluri, D. C. Guttridge, NF-κB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol. Cell. Biol. 27, 4374-4387 (2007).
51. E. Ardite, J. A. Barbera, J. Roca, J. C. Fernández-Checa, Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-κB activation. Am. J. Pathol. 165, 719-728 (2004).
52. R. C. Langen, J. L. Van Der Velden, A. M. Schols, M. C. Kelders, E. F. Wouters, Y. M. Janssen-Heininger, Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J. 18, 227-237 (2004).
53. S. Tay, J. J. Hughey, T. K. Lee, T. Lipniacki, S. R. Quake, M. W. Covert, Single-cell NF-κB dynamics reveal digital activation and analogue information processing. Nature 466, 267-271 (2010).
54. R. Cheong, A. Rhee, C. J. Wang, I. Nemenman, A. Levchenko, Information transduction capacity of noisy biochemical signaling networks. Science 334, 354-358 (2011).
55. Q. Han, N. Bagheri, E. M. Bradshaw, D. A. Hafler, D. A. Lauffenburger, J. C. Love, Polyfunctional responses by human T cells result from sequential release of cytokines. Proc. Natl. Acad. Sci. U.S.A. 109, 1607-1612 (2012).
56. T. K. Lee, E. M. Denny, J. C. Sanghvi, J. E. Gaston, N. D. Maynard, J. J. Hughey, M. W. Covert, A noisy paracrine signal determines the cellular NF-κB response to lipopolysaccharide. Sci. Signal. 2, ra65 (2009).
57. R. Morosetti, C. Gliubizzi, C. Sancricca, A. Broccolini, T. Gidaro, M. Lucchini, M. Mirabella, TWEAK in inclusion-body myositis muscle: Possible pathogenic role of a cytokine inhibiting myogenesis. Am. J. Pathol. 180, 1603-1613 (2012).
58. L. Zhi-Chun, Z. Qiao-Ling, L. Zhi-Qin, L. Xiao-Zhao, Z. Xiao-Xia, T. Rong, Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis. Inflammation 35, 935-943 (2012).
59. M. Kumar, D. Y. Makonchuk, H. Li, A. Mittal, A. Kumar, TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-β-activated kinase 1. J. Immunol. 182, 2439- 2448 (2009).
60. A. Mittal, S. Bhatnagar, A. Kumar, P. K. Paul, S. Kuang, A. Kumar, Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice. Am. J. Pathol. 177, 1732-1742 (2010).
61. S. E. Chen, E. Gerken, Y. Zhang, M. Zhan, R. K. Mohan, A. S. Li, M. B. Reid, Y. P. Li, Role of TNF-a signaling in regeneration of cardiotoxin-injured muscle. Am. J. Physiol. Cell Physiol. 289, C1179-C1187 (2005).
62. S. E. Chen, B. Jin, Y. P. Li, TNF-α regulates myogenesis and muscle regeneration by activating p38 MAPK. Am. J. Physiol. Cell Physiol. 292, C1660-C1671 (2007).
63. S. Bhatnagar, A. Mittal, S. K. Gupta, A. Kumar, TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases. J. Cell. Physiol. 227, 1042 -1051 (2012).
64. M. Holcik, C. A. Lefebvre, K. Hicks, R. G. Korneluk, Cloning and characterization of the rat homologues of the Inhibitor of Apoptosis protein 1, 2, and 3 genes. BMC Genomics 3, 5 (2002).
65. F. Messina, M. Botta, F. Corelli, M. P. Schneider, F. Fazio, Resolution of (+/-)-1-aryl-2-propynylamines via acyltransfer catalyzed by Candida antarctica lipase. J. Org. Chem. 64, 3767-3769 (1999).
66. H. Sun, Z. Nikolovska-Coleska, J. Lu, J. L. Meagher, C. Y. Yang, S. Qiu, Y. Tomita, Y. Ueda, S. Jiang, K. Krajewski, P. P. Roller, J. A. Stuckey, S. Wang, Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP. J. Am. Chem. Soc. 129, 15279-15294 (2007).
67. D. J. Cram, N. L. Allinger, H. Steinberg, Macro rings. VII. The spectral consequences of bringing two benzene rings face to face. J. Am. Chem. Soc. 76, 6132-6141 (1954).
68. A. Hamzé, E. Rubi, P. Arnal, M. Boisbrun, C. Carcel, X. Salom-Roig, M. Maynadier, S. Wein, H. Vial, M. Calas, Mono- and bis-thiazolium salts have potent antimalarial activity. J. Med. Chem. 48, 3639-3643 (2005).
69. H. Ito, Y. Ishida, K. Saigo, Regio- and diastereo-controlled synthesis of bis(formylmethano)[60]fullerenes and their application to the formation of [60]fullerene pearl-necklace polyimines. Tetrahedron Lett. 47, 3095-3098 (2006).
70. S.-I. Kajiyama, K. Irie, T. Kido, K. Koshimizu, H. Hayashi, M. Arai, Synthesis of new indolactam analogues by microbial conversion. Tetrahedron 47, 5453- 5462 (1991).
71. M. Angiolini, S. Araneo, L. Belvisi, E. Cesarotti, A. Checchia, L. Crippa, L. Manzoni, C. Scolastico, Synthesis of azabicycloalkane amino acid scaffolds as reverse-turn inducer dipeptide mimics. Eur. J. Org. Chem. 2000, 2571-2581 (2000).
72. H. Sun, Z. Nikolovska-Coleska, C. Y. Yang, L. Xu, M. Liu, Y. Tomita, H. Pan, Y. Yoshioka, K. Krajewski, P. P. Roller, S. Wang, Structure-based design of potent, conformationally constrained Smac mimetics. J. Am. Chem. Soc. 126, 16686-16687 (2004).
73. V. V. Rostovtsev, L. G. Green, V. V. Fokin, K. B. Sharpless, A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew. Chem. Int. Ed. Engl. 41, 2596-2599 (2002).